Cigna Group (CI) stock

CINYSEHospital & Medical Service PlansFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3021% below fair value

$301.45−1.68 (-0.55%)

Close on Nov 11, 2026Market cap $79.66BP/E 13.3Yield 2.00%

Cigna r&d expenses

Research and development expenses are spending on new products and technology.

Cigna has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CI.

Revenue growth6.8% · median 6.5%

Gross margin20.7% · median 50.6%

Operating margin3.4% · median 1.5%

Net margin2.1% · median 0.8%

Advertisement
300 × 250

See a number that looks wrong?